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Abstract
This case report describes false shortening of activated partial thromboplastin time (aPTT) due to erroneous optical reading of the clotting point in 
the presence of unfractionated heparin (UFH), and a biphasic waveform. 
Activated partial thromboplastin time performed on a coagulometer with photo-optical detection yielded an ambiguous clotting curve charac-
terized by an early and steady decrease in light transmittance throughout the whole measuring range, with the clotting point read at 65 seconds. 
Further investigations included measurement of aPTT by means of a mechanical clot detection method as well as determination of another hepa-
rin-sensitive coagulation assay, that is thrombin time (TT), both being unmeasurably prolonged (> 150 seconds). Communication with clinicians 
revealed that the patient was on continuous UFH therapy and had an underlying sepsis, with highly elevated C-reactive protein (289 mg/L). The aPTT 
measurements requested at three timepoints later during the same day revealed gradual aPTT shortening and unveiled a peculiar biphasic wave-
form pattern. 
In this case, unmeasurably prolonged aPTT due to UFH therapy was masked by a biphasic aPTT curve pattern making only the first slope of the 
biphasic waveform visible within the measuring range. The early decrease in plasma light transmittance mimicked optical changes related to clot 
formation, thus causing erroneous optical reading and yielding a falsely shortened aPTT. This case emphasizes that such a pattern should be care-
fully inspected, especially when a combination of a critically ill condition and UFH therapy is present, in order to prevent erroneous reporting of aPTT 
and potential adverse effects on patient care.
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Introduction
Activated partial thromboplastin time (aPTT) is a 
widely used coagulation test intended for screen-
ing of clotting factor deficiencies within intrinsic 
and common coagulation pathways, for detecting 
presence of circulating inhibitors such as lupus anti-
coagulant, and for therapeutic monitoring of un-
fractionated heparin (UFH). The principle of the test 
is based on measuring platelet-poor plasma clot-
ting time after addition of contact activators, phos-
pholipids and calcium. The test is nowadays usually 
performed on fully automated or semiautomated 
coagulometers with photo-optical or mechanical 
detection. Clot formation is identified by a change 
in optical density (OD) of the reaction mixture and 
aPTT is defined as elapsed time in seconds when 
the reaction mixture OD has exceeded a predefined 
threshold (1). Interfering substances that change 
the sample OD inevitably influence optical coagu-
lometer readings (2). Besides the well-documented 
effects of hemolysis, icterus and lipemia on aPTT 
determination, it has been reported that in some 
critically ill conditions deviations from the normal 
sigmoidal OD curve pattern can occur, leading to 
erroneous optical readings (2,3). The most common 
example is the biphasic waveform which can be en-
countered in patients with hemostatic dysfunction 
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caused by disseminated intravascular coagulation 
(DIC) and sepsis (1,4).
Hereby, we present an unusual case of a falsely 
shortened aPTT result due to erroneous optical 
reading of the clotting point in the presence of 
both UFH and a biphasic waveform. 
Case report
Activated partial thromboplastin time was re-
quested as part of routine laboratory monitoring 
of UFH therapy. A blood sample drawn into a 4.5 
mL 0.105 M (3.2%) trisodium citrate vacutainer 
(Becton Dickinson, Plymouth, United Kingdom) 
was promptly delivered to the Department of Lab-
oratory Diagnostics, University Hospital Centre Za-
greb, Croatia. Upon receipt, the sample was pro-
cessed without delay according to standard labo-
ratory operation procedure, i.e. visual inspection 
for clots followed by centrifugation of the sample 
tube at 2000xg for 15 minutes at room tempera-
ture within one hour from blood collection. The 
obtained plasma was clear, without visible turbidi-
ty or haemolysis.
Activated partial thromboplastin time determina-
tion was performed by coagulometric method us-
ing Dade Actin FS and Calcium Chloride (Siemens 
Healthcare, Marburg, Germany) with photo-opti-
cal clot-detection system on the Sysmex CS-5100 
automated coagulation analyser (Siemens Health-
care, Marburg, Germany) according to manufac-
turer’s recommendations. A normal aPTT meas-
urement curve is shown in Figure 1.
An ambiguous aPTT result was obtained and 
therefore numerical result was omitted and re-
placed by asterisks (******). The analyser software 
generated a flag indicating that further review by 
laboratory staff was required. The clotting point 
read by the analyser was at 65 seconds (reference 
interval: 24-33 seconds). Detailed visual inspection 
revealed an atypical clotting curve as shown in 
Figure 2A, accompanied by a flag indicating Early 
reaction error: Slow reaction, which raised a suspi-
cion about a non-specific initial decrease in light 
transmittance and interference in optical reading.
Therefore, we additionally performed aPTT meas-
urement by a mechanical clot detection method 
utilizing the semiautomated dual-channel BEHRING 
Fibrintimer (Sysmed Lab, Europe Inc., Poland) ana-
lyser and using the same reagents as for the optical 
method. No clot formation was detected and an 
unmeasurable aPTT was obtained (> 150 seconds).
Since the most common cause of aPTT prolonga-
tion is heparin presence, we performed another 
heparin-sensitive coagulation assay - thrombin 
time (TT). The measurement was done utilizing 
Test Thrombin reagent (Siemens Healthcare, Mar-
burg, Germany) on the Sysmex CS-5100 analyser. 
An unmeasurably prolonged result was observed 
(> 150 seconds, reference interval: 16-18 seconds).
Figure 1. A normal, sigmoidal activated partial thromboplastin time (aPTT) clotting curve with an initial plateu, followed by decrease 
in light transmittance due to clot formation and a final plateau once the clot formation is completed. The clotting point is set at 50% 
























ry Start point of reaction





https://doi.org/10.11613/BM.2021.021003 Biochem Med (Zagreb) 2021;31(2):021003 
  3
Lapić I. et al. Paradoxical shortening of aPTT in a patient on heparin
Further investigation of the case, done through 
communication with clinicians, revealed that the 
patient was treated with extracorporeal mem-
brane oxygenation (ECMO) after a cardiorespirato-
ry arrest and therefore inevitably required contin-
uous UFH infusion. The patient’s condition was ad-
ditionally complicated by sepsis, as confirmed by 
blood culture, and by a markedly elevated C-reac-
tive protein (CRP) of 289 mg/L (reference interval: 
< 5 mg/L). Procalcitonin was not requested since it 
was not needed for case clarification.
Furthermore, aPTT for the same patient was re-
quested three more times during the same day, i.e. 
3, 7 and 11 hours after the initial blood draw, with 
clotting curves as shown in Figures 2B-2D, respec-
tively. These subsequent analyses revealed gradu-
al aPTT shortening and unveiled a peculiar bipha-
sic waveform pattern which was not visible in the 
initial aPTT determination due to unmeasurably 
prolonged aPTT. Figure 2D represents a typical bi-
phasic aPTT waveform.
Figure 2. aPTT clotting curves with clotting points obtained on the coagulometer with photo-optical detection and accompanying 
analyser flags at (A) initial blood draw, after (B) 3 hours, (C) 7 hours and (D) 11 hours; The biphasic waveforms are in (A) and (B), and to 
a less extent in (C), masked by a prolonged aPTT due to unfractionated heparin, and caused erroneous optical reading of the clotting 
point; Reported aPTT values were in cases (A) and (B) obtained using the mechanical clot detection method, while for (C) by manual 
reading of the clotting point at 50 % of the secondary decreasing slope of the clotting curve obtained photo-optically; (D) represents 
a typical biphasic aPTT waveform with proper photo-optical reading of the clotting point which corresponds to the reported aPTT. 
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What happened?
Unmeasurably prolonged aPTT due to UFH thera-
py was masked by a biphasic aPTT curve pattern, 
making only the first slope of the biphasic wave-
form visible within the measuring range. Early de-
crease in plasma light transmittance mimicked op-
tical changes related to clot formation, thus caus-
ing erroneous optical reading and yielding a false-
ly shortened aPTT. 
Discussion
Automated coagulation analysers with photo-op-
tical detection measure a change in light transmit-
tance in the reaction mixture during the entire 
clotting process and yield an appropriate curve. 
Regular clotting curves have an initial, horizontal 
plateau with no change in light transmittance, fol-
lowed by an abrupt decrease once the coagula-
tion process begins due to fibrin polymerisation, 
ending with a final, steady-state plateau when clot 
formation is completed, eventually forming a sig-
moid-shaped curve (1,4). Abnormal biphasic clot-
ting curves due to non-clot formation-related 
changes of light transmittance, as those described 
herein, trigger a particular analyzer flag and inevi-
tably require visual inspection by the operator. 
Typical biphasic aPTT waveforms are characterized 
by absence of the initial plateau coupled with im-
mediate, steady decline in light transmittance in 
the early precoagulation phase, followed by a sec-
ondary, sigmoidal decreasing slope when clot for-
mation actually occurs (5). This is thought to be at-
tributable to the rapid formation of Ca2+-depend-
ent macroscopic complex consisting of CRP and 
very low density lipoprotein (VLDL) that is trig-
gered by recalcification of citrate plasma through 
addition of aPTT reagents. This immediately caus-
es changes in the reaction mixture OD, reflected 
as an early drop in light transmittance (5). Al-
though the underlying mechanism has not been 
completely elucidated, it was suggested that both 
a substantially elevated CRP and adequate levels 
of VLDL that exhibit a high surface activity for pro-
thrombin activation are necessary for the complex 
formation (1,5). The reaction itself requires calcium 
ions, but does not depend on the composition of 
the aPTT reagent. Such pattern can be seen in crit-
ically ill patients with conditions that often lead to 
DIC, the most common being sepsis, but also in 
cases of trauma, severe burns or malignancies (4). 
Earlier studies have shown that the presence of a 
biphasic waveform is associated with increased 
mortality rates and can be an early indicator of ad-
verse outcomes (4,6-8). Given the diagnosis of sep-
sis and a concomitant high CRP level in the stud-
ied case, it can be highly suspected that the ob-
served biphasic waveform resulted from the for-
mation of CRP-VLDL complexes once the plasma 
recalcification had occurred. Unlike other de-
scribed cases, this one was additionally complicat-
ed by UFH therapy that caused aPTT prolongation, 
masked the biphasic shape of the clotting curve 
and paradoxically yielded false shortening of aPTT 
when measured photo-optically.
The nowadays less frequently used semiautomat-
ed mechanical clot detection method was a valua-
ble alternative in our case since it simply measures 
the clotting endpoint by detecting changes in the 
movement of a steel ball or rod in the reaction cu-
vette, and is therefore not susceptible to optical 
interferences (3). This method revealed an un-
measurable aPTT, a result which was consistent 
with UFH therapy that the patient was receiving 
during ECMO support. The presence of UFH in the 
sample was further supported by unmeasurably 
prolonged TT. Heparin binds to antithrombin and 
in that way exhibits its inhibitory effect on throm-
bin, prolonging both aPTT and TT (9). Neither D-
dimers nor fibrinogen were concomitantly deter-
mined to evaluate the possible development of 
DIC, which could have elucidated the underlying 
pathophysiological cause of the interference.
What YOU should/can do in your 
laboratory to prevent such errors
•	 A biphasic aPTT clotting curve should be con-
sidered when an early and progressive de-
crease in light transmittance is present.
•	 Such pattern should serve as an alert for a pos-
sible underlying interference in optical reading 
that might require manual reading of the clot-
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ting point or even adoption of a mechanical 
clot detection method.
•	 Special attention should be given to the combi-
nation of a critically ill condition, most com-
monly sepsis or DIC, and UFH therapy which 
can result in an ambiguous biphasic aPTT wave-
form where the slope related to clot formation 
is not present due to the anticoagulant effect of 
UFH.
•	 Biological interference should not be over-
looked as a potential source of preanalytical er-
rors in coagulation testing.
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